GlassScriptPhysician profile
Abigail Davison
NPI 1023659281
$606.58
in general payments reported to CMS, 2019-2025
17 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.61 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $124.74 | 2025 | |
| Janssen Biotech, INC. | $68.14 | 2025 | Rybrevant, Tecvayli |
| Tersera Therapeutics LLC | $60.62 | 2025 | Zoladex |
| Genentech USA, INC. | $49.49 | 2025 | Polivy, Tecentriq |
| Alexion Pharmaceuticals, INC. | $47.61 | 2022 | |
| Jazz Pharmaceuticals INC. | $36.62 | 2025 | |
| Emd Serono, INC. | $24.65 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.10 | 2025 | Iclusig |
| Merck Sharp & Dohme LLC | $22.75 | 2025 | Keytruda |
| Array Biopharma INC | $22.31 | 2025 | Tukysa, Xtandi, Braftovi |
| Incyte Corporation | $21.68 | 2025 | Monjuvi |
| Astrazeneca Pharmaceuticals LP | $21.17 | 2025 | |
| Agios Pharmaceuticals, INC. | $19.60 | 2025 | Pyrukynd |
| Servier Pharmaceuticals LLC | $18.80 | 2025 | |
| Fresenius Kabi USA, LLC | $17.77 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.42 | 2025 | |
| Iovance Biotherapeutics, INC. | $10.11 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Davison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.